By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Nymox Pharmaceutical Corporation (NYMXF)

OTC Currency in USD
$0.05
$0.00
-4.00%
Last Update: 3 Sept 2025, 19:47
$4.63M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.31
52 Week Range

NYMXF Stock Price Chart

Explore Nymox Pharmaceutical Corporation interactive price chart. Choose custom timeframes to analyze NYMXF price movements and trends.

NYMXF Company Profile

Discover essential business fundamentals and corporate details for Nymox Pharmaceutical Corporation (NYMXF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

22 Dec 1997

Employees

CEO

Paul Averback DABP,

Description

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in various clinical trials for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert for detecting tobacco product usage; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, the Bahamas.

NYMXF Financial Timeline

Browse a chronological timeline of Nymox Pharmaceutical Corporation corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 1 Jan 2026

Upcoming earnings on 1 Jan 2026

Earnings released on 3 Jul 2025

Earnings released on 3 Jul 2025

Earnings released on 3 Jun 2025

EPS came in at -$0.01 .

Earnings released on 27 Dec 2024

EPS came in at -$0.01 .

Earnings released on 29 Aug 2024

EPS came in at -$0.06 .

Earnings released on 28 Jun 2024

Earnings released on 28 May 2024

EPS came in at -$0.06 .

Earnings released on 15 Nov 2023

EPS came in at -$0.01 .

Earnings released on 14 Aug 2023

EPS came in at -$0.01 .

Earnings released on 12 May 2023

EPS came in at -$0.02 .

Earnings released on 2 May 2023

EPS came in at -$0.01 .

Earnings released on 29 Sept 2022

EPS came in at -$0.02 .

Earnings released on 29 Jun 2022

EPS came in at $0.01 .

Earnings released on 30 Mar 2022

EPS came in at -$0.06 .

Earnings released on 30 Dec 2021

EPS came in at -$0.03 .

Earnings released on 29 Sept 2021

EPS came in at -$0.04 .

NYMXF Stock Performance

Access detailed NYMXF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run